Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/04/21
End: 02/03/25
Due: 02/03/26
Phase: N/A
Priority: Normal
Start: 02/14/22
End: 08/31/39
Due: 08/31/40
Phase: N/A
Priority: Normal
Start: 11/30/24
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 11/10/24
End: 12/31/27
Due: 12/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase 1 Study of ADI-001 in B Cell Malignancies | NCT04735471 | Adicet Therapeutics | user2@example.com | None | 2021-03-04 | 2025-02-03 | 2026-02-03 | - | - | 2025-07-14 |
| Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells | NCT04911478 | Adicet Therapeutics | user2@example.com | None | 2022-02-14 | 2039-08-31 | 2040-08-31 | - | - | 2025-07-14 |
| A Phase 1/2 Trial of ADI-270 in CcRCC | NCT06480565 | Adicet Therapeutics | user2@example.com | None | 2024-11-30 | 2027-06-30 | 2028-06-30 | - | - | 2025-07-14 |
| A Phase 1 Study of ADI-001 in Autoimmune Disease | NCT06375993 | Adicet Therapeutics | user2@example.com | None | 2024-11-10 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |